Józef Balicki, Paweł Kamiński, Marek Rybak, Zofia Wieczerzańska, Aleksandra Górska, Karolina Rusek, Hanna Tyc, Karolina Pikur, Aaesha Rannath, Małgorzata Drelich
Journal: Wiadomosci lekarskie (Warsaw, Poland : 1960) 2026;79(3):525-532
PMID: 41962092
OBJECTIVE
Aim: Juvenile idiopathic arthritis may remain active into adulthood. This review aims to characterize patients with this condition in terms of quality of life, psychosocial well-being, and various comorbidities, especially those that have recently been described.
PATIENTS AND METHODS
Materials and Methods: Methods involved analyzing studies investigating the mentioned features: meta-analyses, reviews, and cohorts.
CONCLUSION
Conclusions: Results show that quality of life and psychosocial well-being, occupational and social functioning, and, sometimes, cognitive functioning are decreased, while pain and fatigue are increased. In contrast, analyses of emotional health outcomes did not show a higher prevalence of depression or anxiety in adults with JIA. Half of young adults with JIA have active disease, and more than one-third suffer detectable degrees of disability and organ damage. Frequent complaints and conditions are: abdominal pain, TMJ pain, uveitis, and juvenile fibromyalgia syndrome. JIA may also affect BMI, inflammation, and pain of the joints, Growth disorders, overall dysregulation of the immune system, and a negative correlation between disease activity and vitamin D levels. Nevertheless, patients with JIA exhibit lower functional impairment and better quality of life compared to other rheumatic diseases, such as rheumatoid arthritis and spondyloarthropathies. Understanding the lasting impact on health and life satisfaction among adult patients with JIA requires a comprehensive approach that accounts for the multifactorial aspects of the individual's experience with the disease.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.